Alphabet Lore Ai - Search News

Alphabet, Isomorphic and AI drug discovery

‘Solving All Disease’ Using AI is the Mission of Alphabet’s Isomorphic Labs – Its $600M in Funding Will Help

Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical programs, and accelerate disease research.

TechCrunch on MSN · 3d

Alphabet’s AI drug discovery platform Isomorphic Labs raises $600M from Thrive

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

The Wall Street Journal on MSN · 3d

Alphabet-Backed Isomorphic Labs Raises $600 Million for AI Drug Development

The subsidiary of Google parent Alphabet plans to use its first round of external funding to boost its artificial-intelligence drug design pipeline across multiple therapeutic areas.

Alphabet's AI Power Play Is Hiding In Plain Sight - And Investors Are Missing It

Alphabet's AI integration, robust cash flow, and profitable Google Cloud make it a top investment choice. See more on GOOG ...

4don MSN

Is a New AI Model the Catalyst Alphabet Stock Needed?

By itself, Alphabet's new Gemini model may not be a catalyst for the stock, but it is another building block for a company that is showing that it's an innovator. Meanwhile, its recent announcement ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Alphabet, Isomorphic and AI drug discovery

Trending now